Denver, CO, United States
Denver, CO, United States
SEARCH FILTERS
Time filter
Source Type

News Article | May 15, 2017
Site: globenewswire.com

LEIDEN, the Netherlands, May 15, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), remembers co-founder and supervisory board member Henri A. Termeer, who unexpectedly passed away Friday May 12, 2017 at age 71 at his house in Marblehead, MA. “We are devastated by the unexpected passing of our friend and co-founder.” said Daniel A. de Boer, Chief Executive Officer of ProQR. “Henri was a great mentor, a passionate patient advocate and a key factor in establishing ProQR. His passion to do the right thing in the interest of patients is unparalleled. We are honored to have had the opportunity to work with him so closely and learn from his wealth of experience. He was a true inspiration for all of us, and we will continue to build on the path he helped us to set out. Our thoughts go out to Henri’s wife Belinda, his daughter Adriana and his son Nicholas in this very difficult time.” Dinko Valerio, Chairman of the Supervisory Board commented: “Henri’s independent thinking and experience contributed greatly to the start and growth of ProQR. Working with him was an honour and a great pleasure. We will miss a friend and inspirer.” Henri was our co-founder, vice chairman and has served on our supervisory board since January 2014. From October 1983 to June 2011, Henri served as chairman, president and chief executive officer of Genzyme Corporation. For ten years prior to joining Genzyme, Henri worked for Baxter International Laboratories, Inc., a manufacturer of human health care products. Henri resigned from Genzyme in June 2011 following the acquisition of Genzyme by Sanofi. Widely acknowledged for his contributions to the biotechnology industry and health care field, Henri was active in the areas of humanitarian assistance, policy issues, and innovation in providing access to health care. He was a member of the board of each of Massachusetts General Hospital and Partners HealthCare and a member of the board of fellows of Harvard Medical School. Henri was also a member of the board of the Massachusetts Institute of Technology and serves on its Executive Committee and a board member of the Biotechnology Industry Organization (BIO). He was chairman emeritus of the New England Healthcare Institute, a nonprofit, applied research health policy organization he was instrumental in founding. Henri was a board member of ProQR Therapeutics N.V., Abiomed Inc., Aveo Pharmaceuticals, Verastem, Inc., Moderna Therapeutics and Medical Simulation, and was a board member of Allergan, Inc. from 2014 through its acquisition by Actavis in March 2015. In 2008, he was appointed to Massachusetts Governor Deval Patrick’s Council of Economic Advisors. Henri was chairman of the Federal Reserve Bank of Boston’s board of directors from 2010-2011. Henri studied economics at the Economische Hogeschool (Erasmus University, the Netherlands) and earned an MBA from the Darden School at the University of Virginia. ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases such as cystic fibrosis, Leber’s congenital amaurosis Type 10 and dystrophic epidermolysis bullosa. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind.  *Since 2012* A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e641352a-ec62-4e1e-97ed-82ff0ec1d70a


News Article | May 15, 2017
Site: globenewswire.com

LEIDEN, the Netherlands, May 15, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), remembers co-founder and supervisory board member Henri A. Termeer, who unexpectedly passed away Friday May 12, 2017 at age 71 at his house in Marblehead, MA. “We are devastated by the unexpected passing of our friend and co-founder.” said Daniel A. de Boer, Chief Executive Officer of ProQR. “Henri was a great mentor, a passionate patient advocate and a key factor in establishing ProQR. His passion to do the right thing in the interest of patients is unparalleled. We are honored to have had the opportunity to work with him so closely and learn from his wealth of experience. He was a true inspiration for all of us, and we will continue to build on the path he helped us to set out. Our thoughts go out to Henri’s wife Belinda, his daughter Adriana and his son Nicholas in this very difficult time.” Dinko Valerio, Chairman of the Supervisory Board commented: “Henri’s independent thinking and experience contributed greatly to the start and growth of ProQR. Working with him was an honour and a great pleasure. We will miss a friend and inspirer.” Henri was our co-founder, vice chairman and has served on our supervisory board since January 2014. From October 1983 to June 2011, Henri served as chairman, president and chief executive officer of Genzyme Corporation. For ten years prior to joining Genzyme, Henri worked for Baxter International Laboratories, Inc., a manufacturer of human health care products. Henri resigned from Genzyme in June 2011 following the acquisition of Genzyme by Sanofi. Widely acknowledged for his contributions to the biotechnology industry and health care field, Henri was active in the areas of humanitarian assistance, policy issues, and innovation in providing access to health care. He was a member of the board of each of Massachusetts General Hospital and Partners HealthCare and a member of the board of fellows of Harvard Medical School. Henri was also a member of the board of the Massachusetts Institute of Technology and serves on its Executive Committee and a board member of the Biotechnology Industry Organization (BIO). He was chairman emeritus of the New England Healthcare Institute, a nonprofit, applied research health policy organization he was instrumental in founding. Henri was a board member of ProQR Therapeutics N.V., Abiomed Inc., Aveo Pharmaceuticals, Verastem, Inc., Moderna Therapeutics and Medical Simulation, and was a board member of Allergan, Inc. from 2014 through its acquisition by Actavis in March 2015. In 2008, he was appointed to Massachusetts Governor Deval Patrick’s Council of Economic Advisors. Henri was chairman of the Federal Reserve Bank of Boston’s board of directors from 2010-2011. Henri studied economics at the Economische Hogeschool (Erasmus University, the Netherlands) and earned an MBA from the Darden School at the University of Virginia. ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases such as cystic fibrosis, Leber’s congenital amaurosis Type 10 and dystrophic epidermolysis bullosa. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind.  *Since 2012* A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e641352a-ec62-4e1e-97ed-82ff0ec1d70a


This report studies Health and Medical Simulation Products in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering By types, the market can be split into Patient Simulator Surgical Simulator Imaging Simulation Task Trainers By Application, the market can be split into Medical Schools Hospitals Military By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India Global Health and Medical Simulation Products Market Professional Survey Report 2017 1 Industry Overview of Health and Medical Simulation Products 1.1 Definition and Specifications of Health and Medical Simulation Products 1.1.1 Definition of Health and Medical Simulation Products 1.1.2 Specifications of Health and Medical Simulation Products 1.2 Classification of Health and Medical Simulation Products 1.2.1 Patient Simulator 1.2.2 Surgical Simulator 1.2.3 Imaging Simulation 1.2.4 Task Trainers 1.3 Applications of Health and Medical Simulation Products 1.3.1 Medical Schools 1.3.2 Hospitals 1.3.3 Military 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 2 Manufacturing Cost Structure Analysis of Health and Medical Simulation Products 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Health and Medical Simulation Products 2.3 Manufacturing Process Analysis of Health and Medical Simulation Products 2.4 Industry Chain Structure of Health and Medical Simulation Products 8 Major Manufacturers Analysis of Health and Medical Simulation Products 8.1 3B Scientific 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Product A 8.1.2.2 Product B 8.1.3 3B Scientific 2016 Health and Medical Simulation Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 3B Scientific 2016 Health and Medical Simulation Products Business Region Distribution Analysis 8.2 Anesoft 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Product A 8.2.2.2 Product B 8.2.3 Anesoft 2016 Health and Medical Simulation Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Anesoft 2016 Health and Medical Simulation Products Business Region Distribution Analysis 8.3 3D Systems 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Product A 8.3.2.2 Product B 8.3.3 3D Systems 2016 Health and Medical Simulation Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 3D Systems 2016 Health and Medical Simulation Products Business Region Distribution Analysis 8.4 BioDigital 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Product A 8.4.2.2 Product B 8.4.3 BioDigital 2016 Health and Medical Simulation Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 BioDigital 2016 Health and Medical Simulation Products Business Region Distribution Analysis 8.5 B-Line Medical 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Product A 8.5.2.2 Product B 8.5.3 B-Line Medical 2016 Health and Medical Simulation Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 B-Line Medical 2016 Health and Medical Simulation Products Business Region Distribution Analysis 8.6 CAE 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Product A 8.6.2.2 Product B 8.6.3 CAE 2016 Health and Medical Simulation Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 CAE 2016 Health and Medical Simulation Products Business Region Distribution Analysis 8.7 Education Management Solutions (EMS) 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Product A 8.7.2.2 Product B 8.7.3 Education Management Solutions (EMS) 2016 Health and Medical Simulation Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Education Management Solutions (EMS) 2016 Health and Medical Simulation Products Business Region Distribution Analysis 8.8 Gaumard 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Product A 8.8.2.2 Product B 8.8.3 Gaumard 2016 Health and Medical Simulation Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Gaumard 2016 Health and Medical Simulation Products Business Region Distribution Analysis 8.9 Immersion 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Product A 8.9.2.2 Product B 8.9.3 Immersion 2016 Health and Medical Simulation Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Immersion 2016 Health and Medical Simulation Products Business Region Distribution Analysis 8.10 IngMar Medical 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Product A 8.10.2.2 Product B 8.10.3 IngMar Medical 2016 Health and Medical Simulation Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 IngMar Medical 2016 Health and Medical Simulation Products Business Region Distribution Analysis 8.11 Kyoto Kagaku 8.12 Laerdal Medical 8.13 Limbs and Things 8.14 Medical Simulation 8.15 Mentice 8.16 Promodel 8.17 Simbionix 8.18 Simulab 8.19 Simulaids 8.20 Surgical Science For more information, please visit https://www.wiseguyreports.com/sample-request/1274743-global-health-and-medical-simulation-products-market-professional-survey-report-2017


News Article | November 23, 2016
Site: www.newsmaker.com.au

According to Stratistics MRC, the Global Medical Animation Market is accounted for $110.36 million in 2015 and is expected to reach $356.20 million by 2022 growing at a CAGR of 18.2% during the forecast period. Growing penetration of Smartphones, rising usage of medical animation by life sciences & medical device and increasing ageing population are some of the factors fueling the market growth. However, high cost of medical animation services is hampering the market. Emerging economies are offering new growth opportunities for the players in the medical animation market. By technology, 3D animation segment dominated the global market with largest share. By region, North America accounted for largest market share due to the presence of improved healthcare system and availability of advanced technologies. However, Asia Pacific is anticipated to witness highest CAGR, owing to growing awareness levels amongst end users and developing healthcare infrastructure in the region. Some of the key players in Medical Animation market include Ghost Productions, Inc., AXS Studio Inc., Radius Digital Science, Infuse Medical, Scientific Animations, Elara Systems, Inc., Animated Biomedical Productions, Nucleus Medical Media, Understand.Com, XVIVO Scientific Animation, Viscira, Hybrid Medical Animation, Trinsic Animation LLC, Blausen Medical Communications, Inc., Visible Body, Random42 Scientific Communication and INVIVO Communications Inc. Applications Covered: • Cellular and Molecular Studies • Patient Education • Drug Mechanism of Action (MoA) and Approval • Surgical Planning and Training • Other Applications o Forensic Reconstruction o Emergency Care Instruction o Medical Simulation Technologies Covered: • 4D Animation (Real-time Imaging) • 2D Animation • Flash Animation • 3D Animation End-Users Covered: • Life Science Companies • Hospitals and Clinics • Medical Equipment Manufacturers • Pharmaceuticals and Medical Device Manufacturers • Academics Institutes • Other End Users o Government Bodies o Medico-legal Firms o Insurance Companies o Forensic Departments Therapeutic Areas Covered: • Cosmeceutical/Plastic Surgery • Oncology • Dental • Cardiology • Other Therapeutic Areas  o Ophthalmology o ENT o Neurology o Digestive System o Gynecology o Orthopedic Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK  o Spain o Rest of Europe       • Asia Pacific o Japan        o China        o India        o Australia        o New Zealand       o Rest of Asia Pacific • Rest of the World o Middle East o Brazil       o Argentina        o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements


— Growing penetration of Smartphones, rising usage of medical animation by life sciences & medical device and increasing ageing population are some of the factors fueling the market growth. However, high cost of medical animation services is hampering the market. Emerging economies are offering new growth opportunities for the players in the medical animation market. By technology, 3D animation segment dominated the global market with largest share. By region, North America accounted for largest market share due to the presence of improved healthcare system and availability of advanced technologies. However, Asia Pacific is anticipated to witness highest CAGR, owing to growing awareness levels amongst end users and developing healthcare infrastructure in the region. Some of the key players in Medical Animation market include Ghost Productions, Inc., AXS Studio Inc., Radius Digital Science, Infuse Medical, Scientific Animations, Elara Systems, Inc., Animated Biomedical Productions, Nucleus Medical Media, Understand.Com, XVIVO Scientific Animation, Viscira, Hybrid Medical Animation, Trinsic Animation LLC, Blausen Medical Communications, Inc., Visible Body, Random42 Scientific Communication and INVIVO Communications Inc. Applications Covered: • Cellular and Molecular Studies • Patient Education • Drug Mechanism of Action (MoA) and Approval • Surgical Planning and Training • Other Applications o Forensic Reconstruction o Emergency Care Instruction o Medical Simulation End-Users Covered: • Life Science Companies • Hospitals and Clinics • Medical Equipment Manufacturers • Pharmaceuticals and Medical Device Manufacturers • Academics Institutes • Other End Users o Government Bodies o Medico-legal Firms o Insurance Companies o Forensic Departments Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Stratistics MRC We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. For more information, please visit http://www.strategymrc.com/


Marshall S.,Medical Simulation
Anesthesia and Analgesia | Year: 2013

Cognitive aids are prompts designed to help users complete a task or series of tasks. They may take the form of posters, flowcharts, checklists, or even mnemonics. It has been suggested that the use of cognitive aids improves performance and patient outcomes during anesthetic emergencies; however, a systematic assessment of the evidence is lacking. The aim of this literature review was to determine (1) whether cognitive aids improve performance of individuals and teams and (2) whether recommendations can be made for future cognitive aid design, testing, and implementation. Medical, nursing, and psychology databases were searched using broad criteria to find cognitive aids that have been reported in the literature for use in anesthetic emergencies. The reference lists of the articles selected for review were also screened to identify additional studies. Selected articles that described the evaluation of cognitive aids used in anesthetic emergencies were reviewed to determine how the content of the aid was derived, how the design was evaluated, and the success of the aid in improving technical and team performance. The search yielded 22 cognitive aids developed to support clinicians during anesthetic emergencies that had been evaluated in 23 studies. Ten studies using simulation suggested that technical performance improves with the use of cognitive aids in some anesthetic emergencies such as malignant hyperthermia, cardiopulmonary resuscitation, and airway management. However, in 3 of the simulator-based evaluations, participants had either no improvement or took longer to diagnose and treat and made more incorrect diagnoses. Four studies investigated the effect of the aids on teamwork with differing conclusions. One study suggested improved participants' coordination patterns and one found aids improved their decision-making scores, but 2 other studies indicated that there was no improvement and even provided evidence of reduced levels of team communication when teams used a cognitive aid in simulated conditions. The designs of cognitive aids were rarely considered. Education may compensate for a poorly designed aid, but only by ingraining correct actions for situations in which the aid provides little or no guidance. Cognitive aids should continue to be developed from established clinical guidelines where guidelines exist. They would also benefit from more extensive simulation-based usability testing before use. Further evidence is required to explore the effects of cognitive aids in anesthetic emergencies, how they affect team function, and their design considerations. Copyright © 2013 International Anesthesia Research Society.


Littlewood K.E.,Medical Simulation
Best Practice and Research: Clinical Anaesthesiology | Year: 2011

Medical simulation has grown explosively over the last decade.Simulation is becoming commonplace in clinical education but canalso be used as an investigative clinical tool in its own right. Thereare thus two arms of simulation in clinical research. The first is investigation of the clinical impact of simulation as an educationaltool and the second as an instrument to assess the function ofclinical practitioners and systems.This article reviews the terminology, current practice and current research in simulation. The use of simulation in assessment of theclinical performance of devices, people and systems will then be discussed and some current work in these areas presented. Finally, medical simulation will be discussed within the paradigm of translational research. Early examples of this -tool-bench to bedside- model will be presented as possible prototypes for future work directed towards patient safety. © 2011 Elsevier Ltd. All rights reserved.


In depth analysis of Healthcare And Medical Simulation Market is a crucial thing for various stakeholders like investors, CEOs, traders, suppliers and others. The Healthcare And Medical Simulation Market research report is a resource, which provides technical and financial details of the industry. Browse more detail information about Healthcare And Medical Simulation Market at: http://www.360marketupdates.com/europe-healthcare-and-medical-simulation-market-report-2016-10357232 To begin with, the report elaborates the Healthcare And Medical Simulation Market overview. Various definitions and classification of the industry, applications of the industry and chain structure are given. Present day status of the Healthcare And Medical Simulation Market in key regions is stated and industry policies and news are analysed. Next part of the Healthcare And Medical Simulation Market Industry analysis report speaks about the manufacturing process. The process is analysed thoroughly with respect three points, viz. raw material and equipment suppliers, various manufacturing associated costs (material cost, labour cost, etc.) and the actual process. Following are the key players covered in this Healthcare And Medical Simulation Market research report: Get a PDF Sample of Healthcare And Medical Simulation Market Research Report at: http://www.360marketupdates.com/enquiry/request-sample/10357232 After the basic information, the Healthcare And Medical Simulation Market report sheds light on the production. Production plants, their capacities, global production and revenue are studied. Also, the Healthcare And Medical Simulation Market growth in various regions and R&D status are also covered. Following are Major Table of Content of Healthcare And Medical Simulation Industry: • Healthcare And Medical Simulation Production, Revenue (Value) by Region (20Healthcare And Medical Simulation-2021) • Healthcare And Medical Simulation Supply (Production), Consumption, Export, Import by Regions (20Healthcare And Medical Simulation-2021) • Healthcare And Medical Simulation Production, Revenue (Value), Price Trend by Type Get Discount on Healthcare And Medical Simulation Market Research Report at: http://www.360marketupdates.com/enquiry/request-discount/10357232 Further in the Healthcare And Medical Simulation Market Industry Analysis report, the Healthcare And Medical Simulation Market is examined for price, cost and gross capacity. These three points are analysed for types, companies and regions. In continuation with this data sale price for various types, applications and region is also included. The Healthcare And Medical Simulation Market for major regions is given. Scope of the Healthcare And Medical Simulation Industry on the basis of region: Additionally, type wise and application wise consumption figures are also given. With the help of supply and consumption data, gap between these two is also explained. To provide information on competitive landscape, this report includes detailed profiles of Healthcare And Medical Simulation Market key players. For each player, product details, capacity, price, cost, gross and revenue numbers are given. Their contact information is provided for better understanding. In this Healthcare And Medical Simulation Market report analysis, traders and distributors analysis is given along with contact details. For material and equipment suppliers also, contact details are given. New investment feasibility analysis and Healthcare And Medical Simulation Market Industry growth is included in the report. Have any query? Ask our Experts @ http://www.360marketupdates.com/enquiry/pre-order-enquiry/10357232 360 market Updates is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.


The Global Healthcare/Medical Simulation Market is anticipated to raise at a lucrative CAGR of 15.2% from 2016 to 2021, to reach USD 2.27 billion by 2021 from USD 1.12 billion in 2016. The growth in Healthcare/Medical Simulation market is mainly attributed to increasing focus on training of medical practitioners, rising healthcare costs, growing focus on patient safety, consolidation of the manufacturers, and rising demand for minimally invasive technologies. Several manufacturers in the medical simulation industry are increasingly adopting the multidisciplinary approach in their simulation systems to ensure patient safety, effective surgery outcomes, and reduce healthcare costs. Such a trend is expected to promote greater uptake of technologically advanced medical simulation systems in the global medical industry. The research report categorizes the global healthcare/medical simulation market into the following segments and subsegments: The global healthcare/medical simulation market in this report is segmented by products and services, end users, and regions. In 2015, the medical simulation anatomical models segment accounted for the largest share of the global healthcare/medical simulation market, by product & services. The large share of this segment can primarily be attributed to the rising adoption of simulation based learning in medical/nursing schools, increasing healthcare infrastructure, rising number of minimally adhesive surgeries and innovations in patient simulators. The academic institutes segment accounted for the largest share of healthcare/medical simulation market, by end user. This large share for academic institutes is due to increasing awareness of patient safety, focus on minimizing medical errors, and the rising number of medical school enrollees. In addition, the rising educational grants and the improvement of healthcare infrastructure are expected to support the growth of this segment. The Major Players in the Healthcare/Medical Simulation Market Include: Need Assistance (Content, Price, Sample and Discount), Ask Experts @ http://www.absolutereports.com/enquiry/pre-order-enquiry/10350915 Geographically, North America is the major market for medical simulation, accounting for around half of the global market share, followed by Europe and Asia-Pacific. However, Asia-Pacific and Latin America possess lucrative growth potential for the medical simulation market during the forecast period. This is mainly attributed to the extensive customer base in these regions due to large base of aging population and rising prevalence of various disorders. Most of the medical simulation products and services in these regions will be driven by developing countries such as India, China, South Korea, Singapore, Brazil, and Mexico. The global healthcare/medical simulation market is fragmented in nature with the presence of many small and big firms. Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters. For Latest News about Current Market Trends and Forecast Visit At: http://www.absolutereports.com/news/


The Global Health and Medical Simulation Products Market research study is a highly diligent study on competitive landscape analysis, prime manufacturers, marketing strategies analysis, Market Effect Factor Analysis and Consumer Needs by major regions, types, applications in global market.in the past, current and future state of the Global Health and Medical Simulation Products industry. The report provides a thorough overview of the Global Health and Medical Simulation Products market including definitions, classifications, applications and chain structure. Get More Details of This Meticulous Global Health and Medical Simulation Products Market Research Study This report studies Interferons in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Click Here to Get Sample PDF of report Some Key Points of this thorough research:- Want To Customise By Your Requirement? Ask our expert Some of key Tables and Figures included in this research study:- Want a discount? Ask for it Here

Loading Medical Simulation collaborators
Loading Medical Simulation collaborators